1. In the Americas, Revenue declined 12% year-over-year, or 11% at constant currency, to $192 million and represented 38% of total Revenue. Revenue ex-TAC declined 17% year-over-year, or 16% at constant currency, to $72 million and represented 35% of total Revenue ex-TAC.
2. In EMEA, Revenue declined 9% year-over-year, or 7% at constant currency, to $190 million and represented 38% of total Revenue. Revenue ex-TAC declined 12% year-over-year, or 9% at constant currency, to $82 million and represented 40% of total Revenue ex-TAC.
3. In Asia-Pacific, Revenue declined 7% year-over-year, or 6% at constant currency, to $122 million and represented 24% of total Revenue. Revenue ex-TAC declined 8% year-over-year, or 7% at constant currency, to $53 million and represented 25% of total Revenue ex-TAC.
Second quarter 2020 guidance:
We expect Revenue ex-TAC to be between $140 million and $147 million, implying constant-currency decline of approximately 32% to 35%.
Due to the expected significant impact of COVID-19 on our business in the second quarter, we expect Adjusted EBITDA to be between $0 million and $7 million.
The First Quarter 2020 reportQuarter 2020 report seems to have too much negative messages:
1. In the Americas, Revenue declined 12% year-over-year, or 11% at constant currency, to $192 million and represented 38% of total Revenue. Revenue ex-TAC declined 17% year-over-year, or 16% at constant currency, to $72 million and represented 35% of total Revenue ex-TAC.
2. In EMEA, Revenue declined 9% year-over-year, or 7% at constant currency, to $190 million and represented 38% of total Revenue. Revenue ex-TAC declined 12% year-over-year, or 9% at constant currency, to $82 million and represented 40% of total Revenue ex-TAC.
3. In Asia-Pacific, Revenue declined 7% year-over-year, or 6% at constant currency, to $122 million and represented 24% of total Revenue. Revenue ex-TAC declined 8% year-over-year, or 7% at constant currency, to $53 million and represented 25% of total Revenue ex-TAC.
Second quarter 2020 guidance:
We expect Revenue ex-TAC to be between $140 million and $147 million, implying constant-currency decline of approximately 32% to 35%.
Due to the expected significant impact of COVID-19 on our business in the second quarter, we expect Adjusted EBITDA to be between $0 million and $7 million.